BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 28608304)

  • 1. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
    Schoser B; Eymard B; Datt J; Mantegazza R
    J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
    Hülsbrink R; Hashemolhosseini S
    Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
    Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
    Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
    Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
    J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lambert-Eaton Myasthenic Syndrome].
    Matsuo H
    Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton Myasthenic Syndrome.
    Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
    Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to active zone protein ERC1 in Lambert-Eaton myasthenic syndrome.
    Huijbers MG; Lipka AF; Potman M; Hensbergen PJ; Titulaer MJ; Niks EH; van der Maarel SM; Klooster R; Verschuuren JJ
    Hum Immunol; 2013 Jul; 74(7):849-51. PubMed ID: 23583364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
    Motomura M; Iwanaga H
    Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifampridine to treat Lambert-Eaton myasthenic syndrome.
    Oh SJ
    Drugs Today (Barc); 2020 Oct; 56(10):623-641. PubMed ID: 33185628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert-Eaton myasthenic syndrome.
    Wirtz PW; Willcox N; van der Slik AR; Lang B; Maddison P; Koeleman BP; Giphart MJ; Wintzen AR; Roep BO; Verschuuren JJ
    J Neuroimmunol; 2005 Feb; 159(1-2):230-7. PubMed ID: 15652424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
    Vincent A; Lang B; Newsom-Davis J
    Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage gated calcium channel antibody-related neurological diseases.
    Bekircan-Kurt CE; Derle Çiftçi E; Kurne AT; Anlar B
    World J Clin Cases; 2015 Mar; 3(3):293-300. PubMed ID: 25789302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.